Tata Medical & Diagnostics in talks with Johnson & Johnson, AstraZeneca for Covid vaccine tie-up

Moderna, with whom Tata initially held talks, has cited its inability to supply vaccines for at least another year on production constraints owing to worker shortage. It will be able to arrange exports next year, Tata group officials said.